These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21734121)

  • 1. Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.
    Akala HM; Eyase FL; Cheruiyot AC; Omondi AA; Ogutu BR; Waters NC; Johnson JD; Polhemus ME; Schnabel DC; Walsh DS
    Am J Trop Med Hyg; 2011 Jul; 85(1):34-41. PubMed ID: 21734121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
    Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
    Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.
    Chaorattanakawee S; Lanteri CA; Sundrakes S; Yingyuen K; Gosi P; Chanarat N; Wongarunkochakorn S; Buathong N; Chann S; Kuntawunginn W; Arsanok M; Lin JT; Juliano JJ; Tyner SD; Char M; Lon C; Saunders DL
    Malar J; 2015 Dec; 14():486. PubMed ID: 26626127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
    Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
    Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drying anti-malarial drugs in vitro tests to outsource SYBR green assays.
    Traore K; Lavoignat A; Bonnot G; Sow F; Bess GC; Chavant M; Gay F; Doumbo O; Picot S
    Malar J; 2015 Feb; 14():90. PubMed ID: 25880553
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.
    Tyner SD; Lon C; Se Y; Bethell D; Socheat D; Noedl H; Sea D; Satimai W; Schaecher K; Rutvisuttinunt W; Fukuda MM; Chaorattanakawee S; Yingyuen K; Sundrakes S; Chaichana P; Saingam P; Buathong N; Sriwichai S; Chann S; Timmermans A; Saunders DL; Walsh DS
    Malar J; 2012 Jun; 11():198. PubMed ID: 22694953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ; Latour C; Lucas C; Colina O; Ringwald P; Picot S
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1172-8. PubMed ID: 17220424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
    Co EM; Dennull RA; Reinbold DD; Waters NC; Johnson JD
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2557-63. PubMed ID: 19349518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.
    Zatra R; Lekana-douki JB; Lekoulou F; Bisvigou U; Ngoungou EB; Ndouo FS
    BMC Infect Dis; 2012 Nov; 12():307. PubMed ID: 23153201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.
    Oladipo OO; Wellington OA; Sutherland CJ
    Diagn Pathol; 2015 Apr; 10():41. PubMed ID: 25928117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SYBR green I and lactate dehydrogenase antimalarial in vitro assay in Plasmodium falciparum field isolates.
    Hawadak J; Chaudhry S; Pande V; Singh V
    J Pharmacol Toxicol Methods; 2023; 124():107472. PubMed ID: 37778462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity.
    Karl S; Wong RP; St Pierre TG; Davis TM
    Malar J; 2009 Dec; 8():294. PubMed ID: 20003396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
    Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
    Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity to antimalarial drugs and polymorphisms in Pfg377 gene in Plasmodium falciparum field isolates from Mewat, India.
    Singh V; Kumar A; Gupta P
    Pathog Glob Health; 2017 Jul; 111(5):225-233. PubMed ID: 28605993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.